Roles of cMET/ErbB3 activation and overexpression in the development or resistance to EGFR inhibitors in NSCLC patients.

被引：0
|
作者：
Ahn, Myung-Ju
Park, Silvia
Sun, Jong-Mu
Ahn, Jin Seok
Park, Keunchil
Langley, Emma J.
Kim, Phillip Sangwook
Singh, Sharat
Lockton, Steve
机构：
[1] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea
[2] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Hematol Oncol,Dept Med, Seoul, South Korea
[3] Prometheus Labs Inc, San Diego, CA USA
[4] Prometheus Therapeut & Diagnost, San Diego, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
11113
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Heregulin-induced activation of ErbB3 by EGFR tyrosine kinase activity promotes tumor growth and metastasis in melanoma cells
    Ueno, Yoko
    Sakurai, Hiroaki
    Tsunoda, Satoshi
    Choo, Min-Kyung
    Matsuo, Mitsuhiro
    Koizumi, Keiichi
    Saiki, Ikuo
    INTERNATIONAL JOURNAL OF CANCER, 2008, 123 (02) : 340 - 347
  • [42] Radiation-induced activation of ErbB2, ErbB3 and IGF-1R in breast carcinoma cells expressing low EGFR levels
    Luo, Xuemei
    Mikkelsen, Ross B.
    CANCER RESEARCH, 2006, 66 (08)
  • [43] Upregulation of ERBB3/HER3 by FOXD3, an adaptive response promoting resistance to RAF/MEK-inhibitors
    Abel, Ethan V.
    Basile, Kevin J.
    Aplin, Andrew E.
    CANCER RESEARCH, 2012, 72
  • [44] Use of DARPP-32 to increase interactions between EGFR and ERBB3 and to promote gastric cancer resistance to gefitinib.
    Zhu, Shoumin
    Belkhiri, Abbes
    Zaika, Alexander
    El-Rifai, Wael
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [45] Emergence of FGFR3-TACC3 fusions as a potential by-pass resistance mechanism to EGFR tyrosine kinase inhibitors in EGFR mutated NSCLC patients
    Ou, Sai-Hong Ignatius
    Horn, Leora
    Cruz, Marcelo
    Vafai, Davood
    Lovly, Christine M.
    Spradlin, Allison
    Williamson, Michael J.
    Dagogo-Jack, Ibiayi
    Johnson, Adrienne
    Miller, Vincent A.
    Gadgeel, Shirish
    Ali, Siraj M.
    Schrock, Alexa B.
    LUNG CANCER, 2017, 111 : 61 - 64
  • [46] The roles of multifunctional protein ErbB3 binding protein 1 (EBP1) isoforms from development to disease
    Hwang, Inwoo
    Ko, Hyo Rim
    Ahn, Jee-Yin
    EXPERIMENTAL AND MOLECULAR MEDICINE, 2020, 52 (07): : 1039 - 1047
  • [47] The roles of multifunctional protein ErbB3 binding protein 1 (EBP1) isoforms from development to disease
    Inwoo Hwang
    Hyo Rim Ko
    Jee-Yin Ahn
    Experimental & Molecular Medicine, 2020, 52 : 1039 - 1047
  • [48] Signaling via ErbB2 and ErbB3 associates with resistance and Epidermal Growth Factor Receptor (EGFR) amplification with sensitivity to EGFR inhibitor gefitinib in head and neck squamous cell carcinoma cells
    Erjala, Kaisa
    Sundvall, Maria
    Junttila, Teemu T.
    Zhang, Na
    Savisalo, Mika
    Mali, Pekka
    Kulmaia, Jarmo
    Pulkkinen, Jaakko
    Grenman, Reidar
    Elenius, Klaus
    CLINICAL CANCER RESEARCH, 2006, 12 (13) : 4103 - 4111
  • [49] Preliminary analysis of biomarkers in plasma by SELDI to predict the response to EGFR tyrosine kinase inhibitors (TKIs) in NSCLC patients.
    Zhang, L.
    Ning, L.
    Zhang, X.
    Pan, Z. Q.
    Wang, X.
    Xu, F.
    Guan, Z. Z.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 411S - 411S
  • [50] LACTB promotes metastasis of nasopharyngeal carcinoma via activation of ERBB3/EGFR-ERK signaling resulting in unfavorable patient survival
    Peng, Li-Xia
    Wang, Ming-Dian
    Xie, Ping
    Yang, Jun-Ping
    Sun, Rui
    Zheng, Li-Sheng
    Mei, Yan
    Meng, Dong-Fang
    Peng, Xing-Si
    Lang, Yan-Hong
    Qiang, Yuan-Yuan
    Li, Chang-Zhi
    Xu, Liang
    Liu, Zhi-Jie
    Guo, Ling-Ling
    Xie, De-Huan
    Shu, Di-Tian
    Lin, Si-Ting
    Luo, Fei-Fei
    Huang, Bi-Jun
    Qian, Chao-Nan
    CANCER LETTERS, 2021, 498 : 165 - 177
12345